Cutaneous manifestations of filovirus infections

International Journal of Dermatology

Volumn 51, Issue 9, 2012, Pages 1037-1043

  Nkoghe, Dieudonné ^a,b   Leroy, Eric Maurice ^a,c   Toung Mve, Médard ^b   Gonzalez, Jean Paul ^a  

^a CENTRE INTERNATIONAL DE RECHERCHES MÉDICALES DE FRANCEVILLE   (Gabon)

^b Ministry of Health   (Gabon)

^c University de Montpellier   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; NUCLEOPROTEIN; PARACETAMOL; VIRUS GLYCOPROTEIN;

ABDOMINAL PAIN; ANOREXIA; ARTHRALGIA; CONVALESCENCE; DEHYDRATION; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; EBOLA HEMORRHAGIC FEVER; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIC; FATIGUE; FILOVIRUS INFECTION; FLU LIKE SYNDROME; HUMAN; IMMUNOHISTOCHEMISTRY; MARBURG HEMORRHAGIC FEVER; MYALGIA; NONHUMAN; PATIENT CARE; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; RASH; REVIEW; SKIN BIOPSY; SKIN MANIFESTATION; SKIN NECROSIS; TACHYPNEA; VERNER MORRISON SYNDROME; VIRUS REPLICATION; WEIGHT REDUCTION;

ANIMALS; EBOLAVIRUS; HEMORRHAGIC FEVER, EBOLA; HUMANS; MARBURG VIRUS DISEASE; MARBURGVIRUS; SKIN DISEASES;

EID: 84865398678     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2011.05379.x     Document Type: Review

References (42)

1. Feldmann H, Kiley MP. Classification, structure and replication of filoviruses. In: Klenk HD, ed. Marburg and Ebola Viruses, Current Topics in Microbiology and Immunology. Berlin: Springer, 1999: 1-21.
2. Towner JS, Sealy TK, Khristova ML, et al. Newly discovered ebola virus associated with hemorrhagic fever outbreak in Uganga. PLoS Pathog 2008; 4: e1000212.
3. Kuhn JH, Calisher CH, ed. Filoviruses. A Compendium of 40 Years of Epidemiological, Clinical, and Laboratory Studies. New York: Springer Wien, 2008: 411 pp.
4. Bausch DG, Nichol ST, Muyembe-Tamfum JJ, et al. Marburg haemorrhagic fever associated with multiple genetic lineages of virus. N Engl J Med 2006; 355: 909-919.
5. Colebunders R, Tshomba A, Van Kerkhove MD, et al. Marburg haemorrhagic fever in Durba and Watsa, Democratic Republic of the Congo: clinical documentation, features of illness, and treatment. J Infect Dis 2007; 196: S148-S153.
6. Leroy EM, Kumulungui B, Pourrut X, et al. Fruit bats as reservoirs of Ebola virus. Nature 2005; 438: 575-576.
7. Towner JS, Pourrut X, Albarino CG, et al. Marburg virus infection detected in a common african bat. PLoS ONE 2007; 2: e764. doi:10.1371/journal.pone.0000764.
8. Leroy EM, Epelboin A, Mondonge V, et al. Human Ebola outbreak resulting from direct exposure to fruit bats in Luebo, Democratic Republic of Congo, 2007. Vector Borne Zoonotic Dis 2009; 9: 723-728. doi:10.1089/vbz.2008.0167.
9. Nkoghe D, Formenty P, Leroy EM, et al. [Multiple Ebola virus haemorrhagic fever outbreaks in Gabon, from October 2001 to April 2002]. Bull Soc Pathol Exot 2005; 98: 224-229.
10. Martini GA. Marburg agent disease in man. Trans Roy Soc Trop Med Hyg 1969; 63: 295-302.
11. Bausch DG, Towner JS, Dowell SF, et al. Assessment of risk of ebola virus transmission from bodily fluid and fomites. J Infect Dis 2007; 196: S142-S147.
12. Nkoghé D, Formenty P, Nnégué S, et al. [Practical guidelines for the management of Ebola infected patients in the field]. Med Trop 2004; 64: 199-204.
13. Ksiazek TG, Rollin PE, Williams AJ, et al. Clinical virology of Ebola hemorrhagic fever (EHF): virus, virus antigen, and IgG and IgM antibody findings among EHF patients in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis 1999; 179(Suppl 1): 177-187.
14. Leroy EM, Baize S, Lu CY, et al. Diagnosis of Ebola haemorrhagic fever by RT-PCR in an epidemic setting. J Med Virol 2000; 60: 463-467.
15. Epelboin A, Marx A, Durand JL. Ebola au Congo: virus, braconnier et fétiche, Mbomo, Décembre 2003. http://www.pathexo.fr/pages/video.html [accessed on 5 August 2011].
16. Bwaka MA, Bonnet M-J, Calain P, et al. Ebola haemorrhagic fever in Kikwit, Democratic Republic of Congo: clinical observations in 103 patients. J Infect Dis 1999; 1: S1-S7.
17. Stille W, Bohle E. Clinical course and prognosis of Marburg ("Green-Monkey") disease. In: Martini GA, Siegert R, eds. Marburg Virus Disease. Berlin: Springer, 1971: 10-18.
18. Martini GA. Marburg virus disease. Clinical syndrome. In: Martini GA, Siegert R, eds. Marburg Virus Disease. Berlin: Springer, 1971: 1-9.
19. Ebola haemorrhagic fever in Sudan, 1976. Report of the WHO/International Study Team. Bull World Health Organ 1978; 56: 247-270.
20. Ebola haemorrhagic fever in Zaire, 1976. Report of the WHO/International Study Team. Bull World Health Organ 1978; 56: 271-293.
21. Mupapa K, Mukundu W, Bwaka MA, et al. Ebola haemorrhagic fever and pregnancy. J Infect Dis 1999; 1: S11-S12.
22. Smith DH, Francis DP, Simpson DIH. African haemorrhagic fever in southern Sudan, 1976: the clinical manifestations. In: Pattyn SR, ed. Ebola Virus Haemorrhagic Fever. Amsterdam: Elsevier, 1978: 27-30.
23. Lamunu M, Lutwama JJ, Kamugisha J, et al. Containing a haemorrhagic fever epidemic: the Ebola experience in Uganda (October 2000-January 2001). Int J Infect Dis 2004; 8: 27-37.
24. Simpson DIH. Marburg and Ebola Virus Infections: A Guide for their Diagnosis, Management and Control. Geneva: World Health Organization, 1977: 28 pp.
25. Todorovitch K, Mocitch M, Klansnja R. Clinical pictures of two patients infected by the Marburg Vervet Virus. In: Martini GA, Siegert R, eds. Marburg Virus Disease. Berlin: Springer, 1971: 19-23.
26. Bhamarapravati N, Burney MI, Drosdov SG et al. Viral Haemorrhagic Fevers: a Report of a WHO Expert Committee. Geneva: World Health Organization, 1985: 126 pp.
27. Piot P, Bureau P, Breman G, et al. Clinical aspects of Ebola virus infection in Yambuku area, Zaire, 1976. In: Pattyn SR, ed. Ebola Virus Haemorrhagic Fever. Amsterdam: Elsevier, 1978: 17-21.
28. Isaacson M, Sureau P, Courteille G, Pattyn SR. Clinical aspects of ebola virus disease at the Ngaliema hospital, Kinshasa, Zaire, 1976. In: Pattyn SR, ed. Ebola Virus Haemorrhagic Fever. Amsterdam: Elsevier, 1978: 22-26.
29. Nkoghé D, Toung Mvé M, Nnégué S, et al. [Isolated case of haemorrhagic fever observed in Gabon during the 2002 outbreak of Ebola but distant from epidemic zones]. Med Trop 2005; 65: 344-356.
30. Okome-Nkoumou M, Kombila M. [A case of Ebola virus hemorrhagic fever in Libreville (Gabon), fatal after evacuation to South Africa]. Med Trop 1999; 59: 411.
31. Amblard J, Obiang P, Edzang S, et al. Identification of the Ebola virus in Gabon in 1994. Lancet 1997; 349: 181-182.
32. World Health Organization. Yellow fever in 1994 and 1995. Wkly Epidemiol Rec 1996; 71: 313-318.
33. International Society for Infectious Diseases. Ebola hemorrhagic fever - Congo. ProMED - mail (archive 20071121.3758). URL http://www.promedmail.org [accessed on 30 June 2011].
34. World Health Organization. Outbreak of Ebola haemorrhagic fever in Yambio, south Sudan, April-June 2004. Wkly Epidemiol Rec 2005; 80: 370-375.
35. Zaki SR, Shieh W-J, Greer PW, et al. A novel immunohistochemical assay for detection of Ebola virus in skin: implications for diagnosis, spread, and surveillance of Ebola hemorrhagic fever. J Infect Dis 1999; 179(Suppl 1): S36-S47.
36. Leroy EM, Rouquet P, Formenty P, et al. Multiple Ebola virus transmission events and rapid decline of Central African wildlife. Science 2004; 303: 387-390.
37. Rouquet P, Froment JM, Bermejo M, et al. Wild animal mortality monitoring and human Ebola outbreaks, Gabon and Republic of Congo, 2001-2003. Emerg Infect Dis 2005; 11: 283-290.
38. Hewlett BS, Epelboin A, Hewlett BL, Formenty P. Medical anthropology and Ebola in Congo: cultural models and humanistic care. Bull Soc Pathol Exot 2005; 98: 230-236.
39. Geisbert TW, Hensley LE, Jahrling PB, et al. Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue: a study in rhesus monkeys. Lancet 2003; 362: 1943-1948.
40. Geisbert TW, Daddario-Dicaprio KM, Geisbert JB, et al. Marburg virus Angola infection of rhesus macaques: pathogenesis and treatment with recombinant nematode anticoagulant protein c2. J Infect Dis 2007; 196(Suppl 2): S372-S382.
41. Jones SM, Feldmann H, Ströber U, et al. Live attenuated recombinant vaccine protect nonhuman primates against Ebola and Marburg viruses. Nat Med 2005; 11: 786-790.
42. Geisbert TW, Daddario-Dicaprio KM, Geisbert JB, et al. Vesicular stomatitis virus- based vaccines protect nonhuman primates against aerosol challenge with Ebola and Marburg viruses. Vaccine 2008; 26: 6894-6900.